All cancer types
Open
Phase 1
This trial is looking at AZD6738 and gemcitabine for solid cancers that have spread to find the best dose to give.
A solid cancer is any cancer apart from the blood cancers. The following are blood cancers:
There are 2 parts to this trial. The 1st part is open to people with any type of cancer. We will add the details about the 2nd part when it is open.
Recruitment start: 15 October 2019
Recruitment end: 31 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Bristi Basu
AstraZeneca UK
CRUK-Cambridge Centre
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge
Last reviewed: 2 June 2025
CRUK internal database number: 16601
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
